Butyl iodide → 5-(N-butyl-N-methylsulfonylamino)-2,3,4,5-tetrahydro-1-benzoxepine
反応式
[CH3:1][S:2]([NH:5][CH:6]1[C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=2[O:10][CH2:9][CH2:8][CH2:7]1)(=[O:4])=[O:3].[H-].[Na+].I[CH2:20][CH2:21][CH2:22][CH3:23]>CN(C=O)C>[CH2:20]([N:5]([CH:6]1[C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=2[O:10][CH2:9][CH2:8][CH2:7]1)[S:2]([CH3:1])(=[O:3])=[O:4])[CH2:21][CH2:22][CH3:23]参加物
5
実験手順
1.0 g of 5-methylsulfonylamino-2,3,4,5-tetrahydro-1-benzoxepine (Example 8a) were reacted with sodium hydride and iodobutane in DMF analogously to Example 11. After recrystallization of the crude product (1.0 g) from isopropanol, 0.4 g of 5-(N-butyl-N-methylsulfonylamino)-2,3,4,5-tetrahydro-1-benzoxepine was obtained, m.p. 78-79° C.
後処理
- customAfter recrystallization of the crude product (1.0 g) from isopropanol
出典と根拠
- ORDレコード
- ord-706621bffc114e4b8cc7a6baa0cdd40c
- 出典データセット
- uspto-grants-2001_12
- 特許番号
- US06333349B1
反応ノート
読み込み中…